These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12510991)

  • 1. Continuation of growth hormone therapy versus placebo in transition-phase patients with growth hormone deficiency: impact on body composition, insulin sensitivity, and thyroid function.
    Jørgensen JO; Nørrelund H; Vahl N; Juul A; Skakkebaek NE; Christiansen JS
    J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1355-60. PubMed ID: 12510991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism.
    Nørrelund H; Vahl N; Juul A; Møller N; Alberti KG; Skakkebaek NE; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 2000 May; 85(5):1912-7. PubMed ID: 10843174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement.
    Roemmler J; Kuenkler M; Schneider HJ; Dieterle C; Schopohl J
    Metabolism; 2010 Mar; 59(3):350-8. PubMed ID: 19800640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
    Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance.
    Hana V; Silha JV; Justova V; Lacinova Z; Stepan JJ; Murphy LJ
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):442-50. PubMed ID: 15049958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
    Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
    Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
    Yuen KC; Dunger DB
    Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
    Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
    Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism.
    Oertel H; Schneider HJ; Stalla GK; Holsboer F; Zihl J
    Psychoneuroendocrinology; 2004 Aug; 29(7):839-50. PubMed ID: 15177699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma agonism modifies the effects of growth hormone on lipolysis and insulin sensitivity.
    Krag MB; Nielsen S; Guo Z; Pedersen SB; Schmitz O; Christiansen JS; Jørgensen JO
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):452-61. PubMed ID: 18331610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influence of long-term growth hormone replacement therapy on body composition, bone tissue and some metabolic parameters in adults with growth hormone deficiency].
    Olsovská V; Siprová H; Beránek M; Soska V
    Vnitr Lek; 2005 Dec; 51(12):1356-64. PubMed ID: 16430102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control.
    Ahn CW; Kim CS; Nam JH; Kim HJ; Nam JS; Park JS; Kang ES; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):444-9. PubMed ID: 16584518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in body composition and fat distribution in growth hormone-deficient prepubertal children during growth hormone therapy.
    Roemmich JN; Huerta MG; Sundaresan SM; Rogol AD
    Metabolism; 2001 May; 50(5):537-47. PubMed ID: 11319714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome.
    Gravholt CH; Hjerrild BE; Naeraa RW; Engbaek F; Mosekilde L; Christiansen JS
    Clin Endocrinol (Oxf); 2005 May; 62(5):616-22. PubMed ID: 15853835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of growth hormone therapy on intermediary metabolism and insulin sensitivity in hypopituitary adults.
    Johnston DG; Al-Shoumer KA; Chrisoulidou A; Kousta E; Beshyah S; Robinson S
    J Endocrinol Invest; 1999; 22(5 Suppl):37-40. PubMed ID: 10442569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
    Wilhelm B; Kann PH
    Med Klin (Munich); 2004 Oct; 99(10):569-77. PubMed ID: 15490072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survivors of childhood acute lymphoblastic leukaemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment.
    Bülow B; Link K; Ahrén B; Nilsson AS; Erfurth EM
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):683-91. PubMed ID: 15579181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone action in puberty: effects by gender.
    Mauras N; Bishop K; Welch S
    Growth Horm IGF Res; 2007 Dec; 17(6):463-71. PubMed ID: 17566776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.